Publisher： Adis International
ISSN： 1173-5503
Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.495, 2006-01, pp. : 4-4
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
PEG IFN-α-2b/ribavirin cost effective for HIV/HCV co-infection
Inpharma, Vol. 1, Iss. 1522, 2006-01 ,pp. :
Access to resources
Recommend
PEG IFN-α-2b/ribavirin cost effective for HIV/HCV co-infection
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 495, 2006-01 ,pp. :
PEG IFN- -2b plus ribavirin worth its cost in chronic hepatitis C
Inpharma, Vol. 1, Iss. 1379, 2003-01 ,pp. :
PEG IFN- -2a/ribavirin superior to IFN- -2a/ribavirin in HCV + HIV
Inpharma, Vol. 1, Iss. 1449, 2004-01 ,pp. :
Hep A vaccination not cost effective for patients with chronic hep C
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 265, 2000-01 ,pp. :